hysical inactivity is estimated to cause as many deaths globally each year as smoking.
Initial models were adjusted for age and accelerometer wear time; a second model was additionally adjusted for potential confounders (Figure) . Analyses of LPA and sedentary behavior were also adjusted for MVPA because these behaviors were correlated (MVPA and LPA minutes per day, r = 0.36; MVPA and sedentary minutes per day, r=−0.44).
At baseline, the mean age was 72.0 years (SD, 5.7 years), and mean wear time was 14.9 h/d (1.3 h/d). The median times of MVPA, LPA, and sedentary behavior were 28, 351, and 503 min/d, respectively. During an average follow-up of 2.3 years, 207 women died. Total volume of PA was inversely related to mortality after adjustment for potential confounders (P for trend=0.002; Figure) . For MVPA, there also was a strong inverse association (P for trend=0.0002). This association persisted in sensitivity analyses that excluded women with cardiovascular disease and cancer and those rating their health as fair/poor or deaths in the first year (data not shown).
For LPA, in age-and wear time-adjusted analysis, there was a significant inverse association (P for trend=0.04). With adjustment for potential confounders and MVPA, this association was no longer apparent (P for trend=0.82). Parallel (but directionally opposite) findings were seen with sedentary behavior (P for trend=0.007 in age-and wear-time adjusted analysis; P for trend=0.99 in analysis adjusted for potential confounders and MVPA).
In this large study of women with triaxial accelerometer-assessed PA, 3 main findings emerged. First, we observed a strong inverse association between overall volume of PA and all-cause mortality. Although this inverse relation is not novel, the magnitude of risk reduction (≈60%-70%, comparing extreme quartiles) was far larger than that estimated from meta-analyses of studies using self-reported PA (≈20%-30%). Second, the strong inverse association for overall volume of activity was attributable primarily to the strong inverse association between MVPA and mortality. Third, we did not find any associations of LPA or sedentary behavior with mortality after accounting for MVPA.
This study is one of the first investigations of PA and a clinical outcome using newer-generation accelerometers capable of measuring activity along 3 planes. Using triaxial instead of uniaxial data increases the sensitivity for recognizing PA, detecting more time in LPA and less time in sedentary behavior.
A few previous studies of device-assessed PA, using mainly uniaxial devices, and mortality have yielded inconsistent findings. 4 In addition, a large number of studies have examined device-assessed sedentary behavior in relation to biomarkers. However, the vast majority are crosssectional studies, limiting the interpretation of findings. 5 The present study adds meaningfully to existing data because of its large sample size, use of triaxial accelerometer data, and investigation of a clinical outcome. Although the short-term follow-up could raise the possibility of reverse causation as an explanation for the findings, we observed a consistent pattern of results after excluding early deaths within 1 year of PA ascertainment. Although we adjusted for potential confounders, they were selfreported (apart from cardiovascular disease and cancer diagnoses, confirmed with medical records) and may have led to overestimates for MVPA. Finally, the overall participation rate among eligible women was 63%. Although this rate compares favorably with other studies that have used devices to measure PA (eg, 44% in the UK Biobank study), it may limit the generalizability of findings.
This study provides support for the 2008 federal guideline recommendation of MVPA, 2 but it does not support either increasing LPA or decreasing sedentary behavior for mortality risk reduction. As PA guidelines are updated, 2 additional data on other clinical outcomes are needed to fully inform any revisions.
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